Correlation Between AptaBio Therapeutics and Daiyang Metal

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AptaBio Therapeutics and Daiyang Metal at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptaBio Therapeutics and Daiyang Metal into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AptaBio Therapeutics and Daiyang Metal Co, you can compare the effects of market volatilities on AptaBio Therapeutics and Daiyang Metal and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptaBio Therapeutics with a short position of Daiyang Metal. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptaBio Therapeutics and Daiyang Metal.

Diversification Opportunities for AptaBio Therapeutics and Daiyang Metal

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between AptaBio and Daiyang is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding AptaBio Therapeutics and Daiyang Metal Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Daiyang Metal and AptaBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptaBio Therapeutics are associated (or correlated) with Daiyang Metal. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Daiyang Metal has no effect on the direction of AptaBio Therapeutics i.e., AptaBio Therapeutics and Daiyang Metal go up and down completely randomly.

Pair Corralation between AptaBio Therapeutics and Daiyang Metal

Assuming the 90 days trading horizon AptaBio Therapeutics is expected to under-perform the Daiyang Metal. But the stock apears to be less risky and, when comparing its historical volatility, AptaBio Therapeutics is 1.19 times less risky than Daiyang Metal. The stock trades about -0.01 of its potential returns per unit of risk. The Daiyang Metal Co is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  357,000  in Daiyang Metal Co on August 28, 2024 and sell it today you would lose (207,600) from holding Daiyang Metal Co or give up 58.15% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy98.96%
ValuesDaily Returns

AptaBio Therapeutics  vs.  Daiyang Metal Co

 Performance 
       Timeline  
AptaBio Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Daiyang Metal 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Daiyang Metal Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

AptaBio Therapeutics and Daiyang Metal Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AptaBio Therapeutics and Daiyang Metal

The main advantage of trading using opposite AptaBio Therapeutics and Daiyang Metal positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptaBio Therapeutics position performs unexpectedly, Daiyang Metal can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daiyang Metal will offset losses from the drop in Daiyang Metal's long position.
The idea behind AptaBio Therapeutics and Daiyang Metal Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity